ALLMedicine™ Pediatric Atopic Dermatitis Center
Research & Reviews 111 results
https://doi.org/10.1093/cei/uxab009
Clinical and Experimental Immunology; Engle SM, Chang CY et. al.
May 14th, 2022 - The pathogenesis of atopic dermatitis (AD) results from complex interactions between environmental factors, barrier defects, and immune dysregulation resulting in systemic inflammation. Therefore, we sought to characterize circulating inflammatory...
https://doi.org/10.1016/j.det.2021.12.002
Dermatologic Clinics; Lockhart MK, Siegfried EC
Apr 4th, 2022 - Atopic dermatitis (AD) is the most common chronic inflammatory skin disease in children. Standard-of-care treatment has been topical therapy. Oral corticosteroids are also commonly used to treat intermittent flares, despite guidelines that recomme...
https://doi.org/10.1007/s00431-021-04341-3 10.1007/s13555-019-0280-7 10.1016/j.adengl.2020.04.012] 10.1016/j.jaad.2018.03.017 10.1016/j.jaad.2018.08.063 10.1016/j.jaad.2006.05.048 10.1001/jamadermatol.2019.3336 10.1016/j.jpeds.2015.10.077 10.1016/j.jaad.2014.03.023 10.1034/j.1399-3038.2002.01005.x 10.1007/s40257-017-0261-5 10.1007/s40257-017-0253-5 10.1001/archdermatol.2011.2267 10.1016/j.jaad.2020.01.044 10.1016/j.jaad.2008.04.025 10.1016/j.clindermatol.2018.05.003 10.1001/jamadermatol.2017.1271
European Journal of Pediatrics; Guraya A, Pandher K et. al.
Jan 23rd, 2022 - Atopic Dermatitis (AD) is a chronic inflammatory skin disease that is broadly characterized by eczematous lesions and pruritus. This condition is detrimental in a multitude of ways, including patient quality of life (QOL), family QOL, economic bur...
https://doi.org/10.1159/000520978
Dermatology (Basel, Switzerland); van Mierlo MMF, Pardo LM et. al.
Jan 19th, 2022 - Interactions between the skin barrier, immune system, and microbiome underlie the development of atopic dermatitis (AD). To investigate the skin and nasal microbiome in relation to filaggrin gene (FLG) mutations. A cross-sectional study including ...
https://doi.org/10.1093/cei/uxab009
Clinical and Experimental Immunology; Engle SM, Chang CY et. al.
Jan 13th, 2022 - The pathogenesis of atopic dermatitis (AD) results from complex interactions between environmental factors, barrier defects, and immune dysregulation resulting in systemic inflammation. Therefore, we sought to characterize circulating inflammatory...
Clinicaltrials.gov 6 results
https://clinicaltrials.gov/ct2/show/NCT03863418
Mar 6th, 2019 - Atopic dermatitis (AD) is a multifactorial, chronic inflammatory skin disorder that results in areas of dry, itchy skin. AD affects up to 20% of children in Western societies and represents a prevalent, burdensome, and psychologically important pe...
https://clinicaltrials.gov/ct2/show/NCT01385527
Jul 6th, 2018 - The purpose of this study is to evaluate whether participation in an Internet-based intervention helps improve atopic dermatitis treatment outcomes.
https://clinicaltrials.gov/ct2/show/NCT02713035
Feb 19th, 2018 - Background Psychological interventions for atopic dermatitis (AD) in children are not well-studied, despite the potential benefits, which may include: decreased need for medications and improved long-term control of both dermatologic symptoms as w...
https://clinicaltrials.gov/ct2/show/NCT03375970
Dec 18th, 2017 - In Taiwan, there are many patients suffer from pediatric atopic dermatitis. Because of the clinical characteristic of repetitive and scratchy, which will affect the patients' quality of life and lead to the medical heavy budget. TCM may play an im...
https://clinicaltrials.gov/ct2/show/NCT02289989
May 10th, 2017 - A single-center, investigator initiated, randomized controlled, double-blind trial will be conducted to determine the effects of an oregano extract in aqueous solution versus 1% hydrocortisone in the treatment of acute-subacute pediatric atopic de...
News 36 results
http://www.mdedge.com/dermatology/article/246290/atopic-dermatitis/dupilumab-effective-pediatric-atopic-dermatitis-across
Sep 18th, 2021 - Key clinical point: Dupilumab improved signs of atopic dermatitis (AD) rapidly and consistently across all anatomical regions in pediatric patients. Major finding: In children, dupilumab improved Eczema Area and Severity Index (EASI) score as earl.
https://www.mdedge.com/dermatology/article/243635/atopic-dermatitis/serum-biomarker-based-patient-clusters-identify
Jul 29th, 2021 - Key clinical point: Analysis of serum biomarker profiles in pediatric patients with atopic dermatitis (AD) indicates the existence of unique endotypes that could predict patients at risk of persistent disease and guide personalized, endotype-drive.
https://reference.medscape.com/viewarticle/951789
Jun 7th, 2021 - Atopic dermatitis (AD) is the most common inflammatory skin disease among children. This chronic disorder is immunologic in nature and is characterized by pruritic lesions. The condition arises by age 5 years in most pediatric patients and often s...
https://reference.medscape.com/viewarticle/944893
Mar 15th, 2021 - Atopic dermatitis, often called atopic eczema, is a chronic, pruritic inflammatory skin condition that typically affects the face (cheeks), neck, arms, and legs but usually spares the groin and axillary regions. It is common worldwide, affecting u...
https://www.mdedge.com/dermatology/article/235185/atopic-dermatitis/are-pediatric-and-adult-dermatitis-same-disease
Doug Brunk
Jan 28th, 2021 - Are pediatric atopic dermatitis and atopic dermatitis the same disease? Dr. Jonathan I.